| Q33939014 | A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine. |
| Q51783585 | A Review of Meningococcal Disease and Vaccination Recommendations for Travelers. |
| Q36279556 | A broad range assay for rapid detection and etiologic characterization of bacterial meningitis: performance testing in samples from sub-Sahara |
| Q37485447 | An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015. |
| Q38011318 | Can we defeat meningococcal disease in low and middle income countries? |
| Q35760344 | Characterization of Carriage Isolates of Neisseria meningitides in the Adolescents and Young Adults Population of Bogota (Colombia) |
| Q90565601 | Characterization of invasive Neisseria meningitidis isolates recovered from children in Turkey during a period of increased serogroup B disease, 2013-2017 |
| Q39660656 | Clinical characteristics and public health management of invasive meningococcal group W disease in the East Midlands region of England, United Kingdom, 2011 to 2013. |
| Q36363154 | Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688. |
| Q61810197 | Cocirculation of Hajj and non-Hajj strains among serogroup W meningococci in Italy, 2000 to 2016 |
| Q38121695 | Consensus recommendation for meningococcal disease prevention in children and adolescents in the Middle East region |
| Q57796585 | Declining incidence of invasive meningococcal disease in South Africa: 2003-2016 |
| Q45121011 | Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa |
| Q38102475 | Emergence of serogroup X meningococcal disease in Africa: need for a vaccine |
| Q33939565 | Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique |
| Q36253028 | Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis |
| Q36254505 | Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage |
| Q38733306 | Global epidemiology of capsular group W meningococcal disease (1970-2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex |
| Q37359946 | Global epidemiology of invasive meningococcal disease |
| Q44677055 | Global epidemiology of meningococcal disease. |
| Q51820388 | Impact of changing epidemiology on vaccination strategies in Africa. |
| Q41666578 | Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales |
| Q36253411 | Is the Emergence of the N. meningitidis Serogroup W ST-11 Hajj Outbreak Unraveling in the New Era of WGS? |
| Q47212171 | Limited impact of adolescent meningococcal ACWY vaccination on group W carriage in university students. |
| Q38654997 | Meningococcal Disease: Epidemiology and Early Effects of Immunization Programs |
| Q44495758 | Meningococcal Disease: The Organism, Clinical Presentation, and Worldwide Epidemiology |
| Q47097240 | Meningococcal arthritis and myopericarditis: a case report. |
| Q37252405 | Meningococcal polysaccharide A O-acetylation levels do not impact the immunogenicity of the quadrivalent meningococcal tetanus toxoid conjugate vaccine: results from a randomized, controlled phase III study of healthy adults aged 18 to 25 years |
| Q34155231 | Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y. |
| Q36286634 | Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa |
| Q41438255 | Mortality from meningococcal disease in the city of São Paulo, Brazil: characteristics and predictors |
| Q36933476 | Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. |
| Q36171431 | Population snapshot of invasive serogroup B meningococci in South Africa from 2005 to 2008 |
| Q37461347 | Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy |
| Q54428810 | Sequence conservation of pilus subunits in Neisseria meningitidis. |
| Q42215157 | Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America |
| Q63369228 | Testing the vaccine potential of PilV, PilX and ComP, minor subunits of Neisseria meningitidis type IV pili |
| Q40461214 | The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. |
| Q53157734 | The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. |
| Q38113259 | The burden and impact of severe and long-term sequelae of meningococcal disease |
| Q37969481 | The changing and dynamic epidemiology of meningococcal disease |
| Q36593391 | The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape. |
| Q30245411 | The importance of surveillance: Group W meningococcal disease outbreak response and control in England |
| Q38044024 | Treatment of bacterial meningitis: an update |
| Q42920029 | Urethritis caused by novel Neisseria meningitidis serogroup W in man who has sex with men, Japan |
| Q46535546 | Vaccine Prevention of Meningococcal Disease in Africa: Major Advances, Remaining Challenges |
| Q48520078 | Whole genome sequencing of the emerging invasive Neisseria meningitidis serogroup W in Sweden |
| Q64064752 | Whole-genome sequencing and characterization of an antibiotic resistant Neisseria meningitidis B isolate from a military unit in Vietnam |
| Q64885663 | cgMLST characterisation of invasive Neisseria meningitidis serogroup C and W strains associated with increasing disease incidence in the Republic of Ireland. |